-
IM Cannabis Clinical Survey Reports Efficacy Of Its Branded Strains For Conditions Such As PTSD, Insomnia, Back Pain, IBS
Friday, June 18, 2021 - 9:10am | 710Read More...IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) released promising results Thursday of a survey that evaluated the effectiveness of seven company-branded medical cannabis strains in treating seven health conditions. What Happened An Israel-based multi-country cannabis operator, IM...
